Alvotech (ALVO) vs Perrigo Company plc (PRGO)

Alvotech and Perrigo Company plc are both Drug Manufacturers Specialty & Generic companies. Perrigo Company plc is the larger, with a market value of $2.3B against $2.1B — 1.1× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against −4.19%. Perrigo Company plc has the higher net margin (−41.9% vs −101.1%) and the lower return on invested capital (−18.1% vs 0.00%). Across the 16 metrics below, Alvotech leads on 8 and Perrigo Company plc on 8.

Valuation

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 19.25
P/S 5.02 0.56 2.11
P/B n/m 0.92 1.78
Price to free cash flow n/m 18.17 16.14
EV/EBITDA n/m n/m 12.58
EV/Sales 8.98 1.26 2.73
Earnings yield (23.93%) (75.17%) (4.38%)
Free cash flow yield (14.39%) 5.50% 0.00%

Profitability

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Gross margin 42.71% 33.26% 53.94%
Operating margin (42.43%) (37.71%) 0.00%
Net margin (101.05%) (41.85%) 0.00%
Free cash flow margin 0.00% 2.88% 0.00%
Return on equity 0.00% (49.65%) (0.40%)
Return on assets 0.00% (19.60%) (3.32%)
Return on invested capital 0.00% (18.06%) 0.00%

Growth

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% (4.19%) 10.01%
EPS growth (last fiscal year) 111.49% (723.20%) 49.06%
Revenue growth, 5-year CAGR — 0.79% 6.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 1.31 0.05
Current ratio 1.65 2.32 2.31
Net debt to EBITDA 9.71 (4.01) 0.97

Dividend

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Dividend yield — 6.98% 1.57%
Payout ratio — — 0.27

Size

Metric ALVO PRGO Drug Manufacturers Specialty & Generic median
Market cap 2.07b 2.29b 276.90m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack